Fx activation process and its use in the preparation of a fxa composition
JP2019043961A
New stabilizing agent for pharmaceutical protein
IL260611A
Process for the purification of a growth factor protein
MX2019013711A
C1-esterase inhibitor preparation.
WO2018210771A1
Method for the production of a recombinant target protein
US2020297893A1
Plasma-based films and methods for making and using the same
BR112018073669A2
fusion protein, composition of a first protein and a second protein, complex of a first protein and a second protein, polynucleotides encoding a fusion protein, polynucleotide-containing vector, polynucleotide-containing host cell, use of a fusion protein, pharmaceutical composition, and pharmaceutical composition for use
EP3254671A1
High concentration immunoglobulin composition for pharmaceutical application
EP3205665A1
Method of separating factor viii from blood products
KR20170010895A
Preparation comprising factor viii and von willebrand factor peptides
AU2015202570A1
New stabilizing agent for pharmaceutical proteins
IL234226A
Improved process for production of fibrinogen and fibrinogen produced thereby
MX2015003877A
Test for hemolytic potential of pharmaceutical products and formulations for risk minimization.
WO2013186352A1
Assay and method for predicting therapeutic efficacy of immunoglobulin therapy in individual patients with relapsing remitting multiple sclerosis (rr-ms)
AU2013203253A1
Process for the purification of a growth factor protein
AU2012266409A1
Assay and method for the identification of individual responsiveness to immunoglobulin therapy
EP2707387A1
A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii
CN103561758A
Method for inactivation/removal of coagulation factors by precipitation
MX2013005384A
A PROCESS FOR REDUCTION AND/OR REMOVAL OF FXI AND FXIa FROM SOLUTIONS CONTAINING SAID COAGULATION FACTORS.
